TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | +500.0% | 903 | +622.4% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -66.7% | 125 | -63.9% | 0.00% | – |
| Q3 2020 | $6,000 | -85.0% | 346 | -84.4% | 0.00% | -100.0% |
| Q2 2020 | $40,000 | +900.0% | 2,213 | +647.6% | 0.00% | – |
| Q1 2020 | $4,000 | -55.6% | 296 | -37.9% | 0.00% | – |
| Q4 2019 | $9,000 | -78.0% | 477 | -79.8% | 0.00% | -100.0% |
| Q3 2019 | $41,000 | +5.1% | 2,366 | +6.6% | 0.00% | 0.0% |
| Q2 2019 | $39,000 | -69.5% | 2,220 | -64.7% | 0.00% | -75.0% |
| Q1 2019 | $128,000 | – | 6,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |